Paper40950996
Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.
Wang H and 3 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report. Papers, record 40950996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40950996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24670080 | Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells. | J Clin Endocrinol Metab | 2014 | https://conductscience.org/library/papers/24670080 | PubMed |
| 2 | 1928065 | C1q nephropathy: a pediatric clinicopathologic study. | Am J Kidney Dis | 1991 | https://conductscience.org/library/papers/1928065 | PubMed |
| 3 | 40228233 | Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials. | Clin J Am Soc Nephrol | 2025 | https://conductscience.org/library/papers/40228233 | PubMed |
| 4 | 31333655 | Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After Mycobacterium tuberculosis Infection. | Front Immunol | 2019 | https://conductscience.org/library/papers/31333655 | PubMed |
| 5 | 33193097 | Use of Rituximab After Orbital Decompression Surgery in Two Grave's Ophthalmopathy Patients Progressing to Optic Neuropathy. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33193097 | PubMed |
| 6 | 19656128 | Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. | Am J Transplant | 2010 | https://conductscience.org/library/papers/19656128 | PubMed |
| 7 | 24326785 | C1q nephropathy in children: clinical characteristics and outcome. | Pediatr Nephrol | 2014 | https://conductscience.org/library/papers/24326785 | PubMed |
| 8 | 19082635 | C1q nephropathy and minimal change nephrotic syndrome. | Pediatr Nephrol | 2009 | https://conductscience.org/library/papers/19082635 | PubMed |
| 9 | 12218324 | De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy? | Nephron | 2002 | https://conductscience.org/library/papers/12218324 | PubMed |
| 10 | 29174175 | Imaging appearances of hepatic tuberculosis: experience with 12 patients. | Clin Radiol | 2018 | https://conductscience.org/library/papers/29174175 | PubMed |
| 11 | 18650484 | Pathology, clinical presentations, and outcomes of C1q nephropathy. | J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18650484 | PubMed |
| 12 | 34670275 | High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. | Blood Adv | 2022 | https://conductscience.org/library/papers/34670275 | PubMed |
| 13 | 31002691 | C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics. | PLoS One | 2019 | https://conductscience.org/library/papers/31002691 | PubMed |
| 14 | 33862010 | Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients. | J Allergy Clin Immunol | 2021 | https://conductscience.org/library/papers/33862010 | PubMed |
| 15 | 21378402 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. | Ann Rheum Dis | 2011 | https://conductscience.org/library/papers/21378402 | PubMed |
| 16 | 30646343 | Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia. | JAMA Netw Open | 2018 | https://conductscience.org/library/papers/30646343 | PubMed |
| 17 | 26742572 | Rituximab Therapy and Infection Risk in Pediatric Renal Transplant Patients. | Exp Clin Transplant | 2016 | https://conductscience.org/library/papers/26742572 | PubMed |
| 18 | 38222154 | Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study. | Cureus | 2023 | https://conductscience.org/library/papers/38222154 | PubMed |
| 19 | 25943103 | A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/25943103 | PubMed |
| 20 | 26499189 | Hepatic tuberculosis: a multimodality imaging review. | Insights Imaging | 2015 | https://conductscience.org/library/papers/26499189 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42464147 | Hepatic and splenic tuberculosis following infliximab therapy for refractory ulcerative colitis: a case report and literature review. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42464147 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40950996
GET https://conductscience.org/api/papers/v1/40950996/references?page=2